International NeuroAIDS: prospects of HIV-1 associated neurological complications

被引:24
|
作者
Trujillo, JR
Jaramillo-Rangel, G
Ortega-Martinez, M
de Oliveira, ACP
Vidal, JE
Bryant, J
Gallo, RC
机构
[1] Univ Maryland, Inst Biotechnol, Inst Human Virol, Baltimore, MD 21201 USA
[2] Inst Infect Dis Emilio Ribas, BR-01246 Sao Paulo, Brazil
[3] Univ Estadual Campinas, Clin Res Unit Human Retrovirol, BR-01246 Sao Paulo, Brazil
关键词
NeuroAIDS; HIV-1; neurotropism; AIDS dementia complex;
D O I
10.1038/sj.cr.7290374
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Neurological complications associated with HIV-1/AIDS are being recognized with a high frequency that parallels the increased number of AIDS cases. The early infiltration by HIV-1 into the nervous system can cause primary and/or secondary neurological complications. The most common neurocognitive disorder is AIDS Dementia Complex (ADC). In developing countries of Asia the three most opportunistic infections are tuberculosis (TB), cryptococcosis, and Pneumocystis carinii pneumonia. Therefore, it is expected that secondary neurological complications due to TB and cryptococcosis will be the most common cause of morbility and mortality in HIV-1/AIDS cases in China. Research of NeuroAIDS in China is necessary to understand the impact and the biology of HIV-1 in the nervous system. Future studies would include, the molecular epidemiology and the description of opportunistic infections associated to HIV-1; the neuropathological description of primary and secondary HIV-1 complications in different groups; the HIV-1 neurotropism and immune response studies for China's unique HIV-1 strains and recombinant forms derived from the nervous system, including experimental models such as the use of transgenic rats; and the study of potential resistant virus, primarily when the anti-retroviral therapy (ART) has not full access in the brain.
引用
收藏
页码:962 / 969
页数:8
相关论文
共 50 条
  • [31] Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection:: Recommendations of an International AIDS Society-USA panel
    Schambelan, M
    Benson, CA
    Carr, A
    Currier, JS
    Dubé, MP
    Gerber, JG
    Grinspoon, SK
    Grunfeld, C
    Kotler, DP
    Mulligan, K
    Powderly, WG
    Saag, MS
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (03) : 257 - 275
  • [32] Neurologic Complications in Treated HIV-1 Infection
    Bhatia, Nisha S.
    Chow, Felicia C.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (07)
  • [33] Neurologic Complications in Treated HIV-1 Infection
    Nisha S. Bhatia
    Felicia C. Chow
    Current Neurology and Neuroscience Reports, 2016, 16
  • [34] Update on the neurological consequences of HIV-1 infection (2006)
    Tardieu, M
    REVUE NEUROLOGIQUE, 2006, 162 (01) : 19 - 21
  • [35] Neurological Complications of HIV Infection
    Farhadian, Shelli
    Patel, Payal
    Spudich, Serena
    CURRENT INFECTIOUS DISEASE REPORTS, 2017, 19 (12)
  • [36] Neurological complications of HIV infection
    McArthur, JC
    Brew, BJ
    Nath, A
    LANCET NEUROLOGY, 2005, 4 (09): : 543 - 555
  • [37] THE NEUROLOGICAL COMPLICATIONS OF HIV INFECTION
    BERGER, JR
    ACTA NEUROLOGICA SCANDINAVICA, 1988, 77 : 40 - 76
  • [38] Neurological complications of HIV infection
    Das, CP
    Sawhney, IMS
    NEUROLOGY INDIA, 1998, 46 (02) : 82 - 93
  • [39] Neurological Complications of HIV Infection
    Shelli Farhadian
    Payal Patel
    Serena Spudich
    Current Infectious Disease Reports, 2017, 19
  • [40] Neurological complications of HIV infection
    Radziwill, AJ
    Kappos, L
    Battegay, M
    Steck, AJ
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 130 (13) : 457 - 470